RxSight Inc

RxSight Inc

RXST

Get informed when a big investor buys or sells

+ Follow
Market Cap$220.64M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
RxSight IncRxSight Inc-4.7--17%1.6-
$11.00

Target Price by Analysts

129.6% upsideRxSight Target Price DetailsTarget Price

Share Statistics

Market cap$220.64 Million
Enterprise Value$213.90 Million
Dividend Yield$- (-)
Earnings per Share$-0.95
Beta1.24
Outstanding Shares41,306,110

Return

Return on Equity-17.45%ROE
Return on Assets-15.34%
Return on Invested Capital-19.21%

Valuation & Multiples

P/E Ratio-4.72P/E Ratio
PEG-5.03PEG
Price to Sales1.6Price to Sales
Price to Book Ratio0.8Price to Book Ratio
Enterprise Value to Revenue1.68
Enterprise Value to EBIT-4.02
Enterprise Value to Net Income-5
Total Debt to Enterprise0.05
Debt to Equity0.04Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 12, 2026
EPS Estimate
$-0.31
Average shareholder expectation
Revenue Estimate
$29.97 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 6, 2026
EPS Estimate
$-0.21
Average shareholder expectation
Revenue Estimate
$32.08 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio4.8525 415.05%
Total Calls12,200 41.35%
Total Puts59,200 305.48%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %92.76% 3.31%
Total Invested$235.20M 38.40%
Investors Holding1640%

ESG Score

No data

About RxSight Inc

2,021 employees